We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 7,397 results
  1. Can research on entactogens contribute to a deeper understanding of human sexuality?

    In recent years, scientific research into the therapeutic potential of psychedelic compounds has experienced a resurgence of interest. New studies...

    Justyna Holka-Pokorska in Pharmacological Reports
    Article Open access 08 November 2023
  2. Effects of carvedilol on human prostate tissue contractility and stromal cell growth pointing to potential clinical implications

    Background

    Apart from antagonizing ß-adrenoceptors, carvedilol antagonizes vascular α 1 -adrenoceptors and activates G protein-independent signaling....

    Sheng Hu, A. Elif Müderrisoglu, ... Martin Hennenberg in Pharmacological Reports
    Article Open access 11 June 2024
  3. Cold chain management practices of non-vaccine commodities in public health facilities of Rwenzori Region, Western Uganda

    Background

    Despite the evidence that cold chain management practices affect the potency and effectiveness of both vaccines and non-vaccine...

    Yona Tumwine, Kalidi Rajab, ... Domina Asingizwe in Journal of Pharmaceutical Policy and Practice
    Article Open access 18 January 2023
  4. Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: A Global Landscape Review

    Background

    Working with patients through meaningful patient engagement (PE) and incorporating patient experience data (PXD) is increasingly important...

    Neil Bertelsen, Lode Dewulf, ... Nicholas Brooke in Therapeutic Innovation & Regulatory Science
    Article Open access 24 September 2023
  5. Development and Validation of a Quantitative Determination Method for Fluorothiazinone in Human Blood Plasma

    An HPLC-MS/MS technique for quantitative determination of the new antibacterial drug fluorothiazinone in human blood plasma using an internal...

    S. N. Baskhanova, M. V. Savitskii, ... S. A. Appolonova in Pharmaceutical Chemistry Journal
    Article 01 February 2024
  6. Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines

    Background

    Essential phospholipids (EPL) are hepatoprotective.

    Methods

    The effects on interleukin (IL)-6 and -8 secretion and on certain...

    Dominik Wupperfeld, Gert Fricker, ... Branko Popovic in Pharmacological Reports
    Article Open access 26 April 2024
  7. Digital Health Technologies in Clinical Trials: An Ontology-Driven Analysis to Inform Digital Sustainability Policies

    Background

    Digital health technologies (DHTs) can facilitate the execution of de-centralized trials that can offer opportunities to reduce the burden...

    Spencer Phillips Hey, Maria Dellapina, ... Jason LaRoche in Therapeutic Innovation & Regulatory Science
    Article Open access 06 August 2023
  8. Thinking outside of the [cold] box: implementing a human-centered design approach to understand barriers and craft solutions to cold chain equipment maintenance in Niger

    Background

    Vaccines require cold chain equipment (CCE) to ensure quality and potency, yet the risk of CCE failing is well-documented, often due to...

    Wendy Prosser, Nicole Danfakha, ... Mata Garba in Journal of Pharmaceutical Policy and Practice
    Article Open access 16 November 2023
  9. Policy developer’s perceptions on the implementation of National Health Insurance in South Africa: a qualitative study

    Background

    Universal health coverage has gained significant momentum internationally as the policy solution to address healthcare system deficiencies...

    Vivian Naidoo, Fatima Suleman, Varsha Bangalee in Journal of Pharmaceutical Policy and Practice
    Article Open access 05 May 2023
  10. Health supply chain system in Uganda: current issues, structure, performance, and implications for systems strengthening

    Background

    The health supply chain system is essential for the optimum performance of the healthcare system. Despite increased investments in the...

    Eric Lugada, Henry Komakech, ... Denis Okidi Ladwar in Journal of Pharmaceutical Policy and Practice
    Article Open access 01 March 2022
  11. Following the COVID-19 playbook and battling another infodemic: conspiracy beliefs around human monkeypox among the Lebanese population

    Introduction

    The non-endemic multicountry outbreak of monkeypox (MPX) has emphasized the issue of conspiracy theories that go viral in times of...

    Dalal Youssef, Lea Bleibel, Edmond Abboud in Journal of Pharmaceutical Policy and Practice
    Article Open access 13 June 2023
  12. Inventory management performance for family planning, maternal and child health medicines in public health facilities of West Wollega zone, Ethiopia

    Background

    Inventory management is the heart of the supply system in improving availability of medicines, reducing the cost, and improving patient...

    Oliyad Kebede, Gizachew Tilahun in Journal of Pharmaceutical Policy and Practice
    Article Open access 15 February 2021
  13. Prevalence and correlates of burnout among Lebanese health care workers during the COVID-19 pandemic: a national cross-sectional survey

    Background

    The COVID-19 pandemic has harshly burdened the healthcare systems. Health care workers (HCWs) are at substantial risk of infection and...

    Dalal Youssef, Edmond Abboud, ... Janet Youssef in Journal of Pharmaceutical Policy and Practice
    Article Open access 16 December 2022
  14. When a neglected tropical zoonotic disease emerges in non-endemic countries: need to proactively fill the unveiled knowledge gaps towards human monkeypox among the Lebanese population

    Introduction

    The ongoing multi-country outbreak of monkeypox (MPX) that emerges in non-endemic areas is a rare and unprecedented event that has...

    Dalal Youssef, Edmond Abboud, ... Janet Youssef in Journal of Pharmaceutical Policy and Practice
    Article Open access 07 March 2023
  15. Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare Diseases

    The literature thoroughly describes the challenges of pediatric drug development for rare diseases. This includes (1) generating interest from...

    Carla Epps, Ralph Bax, ... Jonathan M. Davis in Therapeutic Innovation & Regulatory Science
    Article 26 April 2022
  16. The effect of selected aminoglycoside antibiotics on human serum albumin antioxidant activity: a spectroscopic and calorimetric comparative study

    Background

    Human serum albumin (HSA) is a valuable component of non-enzymatic and endogenous antioxidant mechanisms. The antioxidant activity of HSA...

    Wojciech Rogóż, Kinga Mac, ... Małgorzata Maciążek-Jurczyk in Pharmacological Reports
    Article Open access 13 September 2023
  17. The procurement and supply chain strengthening project: improving public health supply chains for better access to HIV medicines, Uganda 2011–2016

    Background

    With countries moving towards reaching the UNAIDS 90-90-90 goal to achieve HIV epidemic control, there are going to be an unprecedented...

    Sowedi Muyingo, David Etoori, ... Rashid Settaala in Journal of Pharmaceutical Policy and Practice
    Article Open access 27 October 2022
  18. The role of drug regulatory authorities and health technology assessment agencies in sha** incentives for antibiotic R&D: a qualitative study

    Background

    Few antibiotics have entered the market in recent years despite the need for new treatment options. Some of the challenges of bringing new...

    Cecilia Kållberg, Liv Mathiesen, ... Hege Salvesen Blix in Journal of Pharmaceutical Policy and Practice
    Article Open access 27 March 2023
  19. An Innovative Health Literacy Approach Designed to Improve Patient Understanding of Medication Labeling

    Objective

    Limited health literacy negatively impacts understanding of medication-related information. We describe an innovative methodology designed...

    Kara L. Jacobson, Juliette Faughnan, ... Michael S. Wolf in Therapeutic Innovation & Regulatory Science
    Article Open access 02 August 2021
  20. Drug shops for stronger health systems: learning from initiatives in six LMICs

    Background

    Private sector retail pharmacies, or drug shops, play an important role in access to essential medicines and services in...

    Geetanjali Lamba, Zubin Cyrus Shroff, ... Abdul Ghaffar in Journal of Pharmaceutical Policy and Practice
    Article Open access 16 November 2021
Did you find what you were looking for? Share feedback.